Insider · CIK 0001242993

FITZGERALD EDWARD M

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001242993

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	PBLSParabilis Medicines, Inc. · Series B Preferred StockC Conversion	Director	CConversion	+5,332 sh	—	—	0
2026-06-11	PBLSParabilis Medicines, Inc.C Conversion	Director	CConversion	+5,539 sh	—	—	5,539
2026-06-11	PBLSParabilis Medicines, Inc. · Series C Preferred StockC Conversion	Director	CConversion	+3,666 sh	—	—	0
2026-06-11	PBLSParabilis Medicines, Inc. · Series F Preferred StockC Conversion	Director	CConversion	+8,111 sh	—	—	0
2026-06-11	PBLSParabilis Medicines, Inc.C Conversion	Director	CConversion	+5,271 sh	—	—	14,688
2026-06-11	PBLSParabilis Medicines, Inc.C Conversion	Director	CConversion	+3,878 sh	—	—	9,417
2026-06-09	PBLSParabilis Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.2K sh	—	—	20,215
2019-06-14	AKCEA THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+26.4K sh	—	—	26,400
2018-06-01	AKCEA THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+26.4K sh	—	—	26,400
2016-03-21	ARIAD PHARMACEUTICALS INCS Sale	Executive VP	SSale	−5,417 sh	$6.47	−$35K	320,367
2016-03-19	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	Executive VP	MExercise/Conversion	−10.8K sh	—	—	0
2016-03-19	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	Executive VP	MExercise/Conversion	+10.8K sh	—	—	325,784
2016-03-07	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsA Award	Executive VP	AAward	+26.2K sh	—	—	26,180
2016-03-07	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award	Executive VP	AAward	+87.1K sh	$6.51	+$567K	87,125
2016-03-03	ARIAD PHARMACEUTICALS INCS Sale	Executive VP	SSale	−9,625 sh	$6.12	−$58.9K	314,951
2016-03-01	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	Executive VP	MExercise/Conversion	+19.3K sh	—	—	324,576
2016-03-01	ARIAD PHARMACEUTICALS INCPerformance stock unitA Award	Executive VP	AAward	+38.5K sh	—	—	38,500
2016-03-01	ARIAD PHARMACEUTICALS INCPerformance stock unitM Exercise/Conversion	Executive VP	MExercise/Conversion	−19.3K sh	—	—	19,250
2016-02-01	ARIAD PHARMACEUTICALS INCS Sale	Executive VP	SSale	−14.7K sh	$4.81	−$70.5K	305,326
2016-02-01	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	Executive VP	MExercise/Conversion	+29.3K sh	—	—	319,993
2016-02-01	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	Executive VP	MExercise/Conversion	−29.3K sh	—	—	29,333
2015-09-28	ARIAD PHARMACEUTICALS INCS Sale	Executive VP	SSale	−8,750 sh	$6.46	−$56.6K	289,231
2015-09-24	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	Executive VP	MExercise/Conversion	+17.5K sh	—	—	297,981
2015-09-24	ARIAD PHARMACEUTICALS INCPerformance stock unitA Award	Executive VP	AAward	+35K sh	—	—	35,000
2015-09-24	ARIAD PHARMACEUTICALS INCPerformance stock unitM Exercise/Conversion	Executive VP	MExercise/Conversion	−17.5K sh	—	—	17,500
2015-08-28	ARIAD PHARMACEUTICALS INCS Sale	Executive VP	SSale	−32.9K sh	$10.00	−$329K	280,481
2015-07-16	ARIAD PHARMACEUTICALS INCS Sale	Executive VP	SSale	−7,000 sh	$8.54	−$59.8K	313,339
2015-07-15	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	Executive VP	MExercise/Conversion	+14K sh	—	—	320,339
2015-07-15	ARIAD PHARMACEUTICALS INCPerformance stock unitM Exercise/Conversion	Executive VP	MExercise/Conversion	−14K sh	—	—	0
2015-05-01	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Executive VP	MExercise/Conversion	−60K sh	—	—	0
2015-05-01	ARIAD PHARMACEUTICALS INCS Sale	Executive VP	SSale	−60K sh	$8.80	−$528K	305,852
2015-05-01	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	Executive VP	MExercise/Conversion	+60K sh	$7.56	+$454K	365,852
2015-04-29	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsA Award	Executive VP	AAward	+54K sh	—	—	54,000
2015-03-23	ARIAD PHARMACEUTICALS INCS Sale	Executive VP	SSale	−4,167 sh	$8.55	−$35.6K	305,209
2015-03-20	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	Executive VP	MExercise/Conversion	−8,333 sh	—	—	0
2015-03-20	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	Executive VP	MExercise/Conversion	+8,333 sh	—	—	309,376
2015-03-20	ARIAD PHARMACEUTICALS INCS Sale	Executive VP	SSale	−5,417 sh	$8.84	−$47.9K	301,043
2015-03-19	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	Executive VP	MExercise/Conversion	−10.8K sh	—	—	10,833
2015-03-19	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	Executive VP	MExercise/Conversion	+10.8K sh	—	—	306,460
2015-02-02	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	Executive VP	MExercise/Conversion	−29.3K sh	—	—	58,666
2015-02-02	ARIAD PHARMACEUTICALS INCS Sale	Executive VP	SSale	−14.7K sh	$6.33	−$92.8K	295,627
2015-02-02	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	Executive VP	MExercise/Conversion	+29.3K sh	—	—	310,294
2014-09-02	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Executive VP	MExercise/Conversion	−25K sh	—	—	25,000
2014-09-02	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	Executive VP	MExercise/Conversion	−25K sh	—	—	0
2014-09-02	ARIAD PHARMACEUTICALS INCS Sale	Executive VP	SSale	−25K sh	$6.22	−$155K	280,960
2014-09-02	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	Executive VP	MExercise/Conversion	+25K sh	$5.23	+$131K	305,960
2014-09-02	ARIAD PHARMACEUTICALS INCS Sale	Executive VP	SSale	−25K sh	$6.22	−$155K	280,960
2014-09-02	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	Executive VP	MExercise/Conversion	+25K sh	$5.23	+$131K	305,960
2014-07-15	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	Executive VP	MExercise/Conversion	+14K sh	—	—	285,524
2014-07-15	ARIAD PHARMACEUTICALS INCF Tax Payment	Executive VP	FTax Payment	−4,564 sh	$5.57	−$25.4K	280,960

Recent filings

Accepted (ET)
Jun 154
FITZGERALD EDWARD M0001193125-26-271344
SEC(opens sec.gov)
Jun 114
FITZGERALD EDWARD M0001193125-26-267769
SEC(opens sec.gov)
Jun 184
FITZGERALD EDWARD M0001209191-19-037700
SEC(opens sec.gov)
Jun 54
FITZGERALD EDWARD M0001209191-18-035591
SEC(opens sec.gov)
Mar 224
ARIAD PHARMACEUTICALS INC0000884731-16-000020
SEC(opens sec.gov)
Mar 94
ARIAD PHARMACEUTICALS INC0001628280-16-012498
SEC(opens sec.gov)
Mar 34
ARIAD PHARMACEUTICALS INC0001127602-16-044967
SEC(opens sec.gov)
Feb 34
ARIAD PHARMACEUTICALS INC0001127602-16-039303
SEC(opens sec.gov)

Companies

Address

C/O PARABILIS MEDICINES, INC. 30 ACORN PARK DRIVE, 6TH FLOOR

CAMBRIDGE, MA, 02140